Ocean Biomedical Inc.

NASDAQ: OCEA · Real-Time Price · USD
0.01
-0.00 (-16.67%)
At close: May 06, 2025, 3:59 PM
0.01
5.88%
After-hours: May 06, 2025, 04:00 PM EDT
-16.67%
Bid 0.01
Market Cap 2.26M
Revenue (ttm) n/a
Net Income (ttm) -3.3M
EPS (ttm) -0.34
PE Ratio (ttm) -0.04
Forward PE -0.01
Analyst n/a
Ask 0.02
Volume 6,533,614
Avg. Volume (20D) 63,929,061
Open 0.01
Previous Close 0.01
Day's Range 0.01 - 0.02
52-Week Range 0.01 - 2.09
Beta 1.73

About OCEA

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...

Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol OCEA
Full Company Profile
3 months ago
-26.33%
Ocean Biomedical shares are trading higher after t... Unlock content with Pro Subscription